Equinox Gold: Canaccord Reiterates Buy Rating, $12 Price Target

Early this month, Equinox Gold Corp. (TSX: EQX) reported its third quarter financial results. The company announced revenues of $245.1 million, slightly higher than the $244.5 million last year. Gross margins from mining were $49.2 million, adjusted EBITDA was $62 million, while earnings per share came in at -$0.02. The company produced 139,758 ounces of gold while selling 137.144 ounces for the quarter. The average selling gold price was $1,780 while the all-in sustaining price was $1,327.

Equinox Gold currently has 12 analysts covering the stock with an average 1-month price target of C$14.71. Out of the 12 analysts, 1 analyst has a strong buy rating, 9 have buys and 2 analysts have hold ratings. The street high comes from Stifel-GMP and sits at C$20 while the lowest price target is C$10.50.

In Canaccord Genuity’s earnings review, they reiterated their C$12 price target and buy rating, writing, “We continue to like the company for its unrivaled growth trajectory and leverage to gold prices,” but warn that their forecasts expect Equinox to be free cash flow negative into 2023. This could potentially make Equinox’s share price underperform due to a lack of liquidity while in growth mode.

For the quarter, Canaccord says that the majority of their operating results came in line with their estimates except general, administrative, and corporate costs came in higher than expectations. Adjusted EBITDA also came in 30% lower than Canaccord’s $88.5 million estimate. For gold production per mine, the majority either came in-line or slightly beat except for the Mesquite and Mercedes mine which came in 20% and 13% lower than their estimates.

Canaccord believes that management reiterating their full-year guidance is setting up the fourth quarter to be a strong quarter. They believe that the company will produce 212,000 ounces of gold, a 52% increase for the fourth quarter. They expect this will be able to happen thanks to Mesquite and Los Filos production increase.

They say that Equinox’s cash position of $300 million will be able to fund its growth projects but warn that their balance sheet could potentially come under pressure if they don’t find additional sources of liquidity should the average selling price drops below $1,700.

Below you can see Canaccord’s updated estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Recommended

Antimony Resources Drills 8.48% Sb Over 3 Metres, 2.07% Sb Over 27 Metres At Bald Hill

Steadright To Acquire 75% Interest In Moroccan Copper-Lead-Silver Project

Related News

First Majestic Silver Sees BMO Resume Coverage With $13.25 Price Target

On November 30th, First Majestic Silver Corp. (TSX: FR) priced their convertible senior notes due...

Saturday, December 4, 2021, 12:49:00 PM

Trulieve Cannabis: Second Quarter 2021 Analyst Consensus Estimates

Trulieve Cannabis (CSE: TRUL) announced that they will be reporting their second quarter financials before...

Monday, August 9, 2021, 11:32:00 AM

Nuvei: BMO Raises Price Target To $59 Following Preliminary Results

On February 5th, Nuvei Corp (TSX: NVEI) announced preliminary fourth-quarter numbers. They announced total revenue...

Saturday, February 13, 2021, 01:48:00 PM

Antibe Therapeutics: Canaccord Upgrades Price Target To $16.50

Earlier this week, Antibe Therapeutics (TSXV: ATE) announced a strategic licensing deal with Nuance Pharm...

Thursday, February 11, 2021, 04:07:00 PM

Tyson Foods Sees BMO Lower Price Target On Underlying Fundamental Market Issues

This week BMO Capital Markets’ elected to cut both their 12-month price target and as...

Saturday, March 19, 2022, 03:11:00 PM